Last CNY4.56 CNY
Change Today 0.00 / 0.00%
Volume 4.7M
600488 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

tianjin tianyao pharm-a (600488) Snapshot

Open
CNY4.56
Previous Close
CNY4.56
Day High
CNY4.60
Day Low
CNY4.51
52 Week High
10/11/13 - CNY5.12
52 Week Low
01/14/14 - CNY3.82
Market Cap
4.4B
Average Volume 10 Days
6.0M
EPS TTM
CNY0.05
Shares Outstanding
960.9M
EX-Date
05/21/14
P/E TM
91.4x
Dividend
CNY0.02
Dividend Yield
0.39%
Current Stock Chart for TIANJIN TIANYAO PHARM-A (600488)

Related News

No related news articles were found.

tianjin tianyao pharm-a (600488) Related Businessweek News

No Related Businessweek News Found

tianjin tianyao pharm-a (600488) Details

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and sale of pharmaceutical APIs in Asia. The company primarily offers corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. Its product portfolio includes bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, methylprednisolone hemisuccinate, hydrocortisone butyrate, hydrocortisone, hydrocortisone acetate, methylprednisolone, triamcinolone, bucinnazine hydrochloride, and flunarizine hydrochloride. Tianjin Tianyao Pharmaceuticals Co., Ltd. also offers formulations, which include triamcinolone, dexamethasone acetate, prednisone acetate, and methylprednisolone tablets. The company also exports its products. Tianjin Tianyao Pharmaceuticals Co., Ltd. is based in Tianjin, China.

tianjin tianyao pharm-a (600488) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianjin tianyao pharm-a (600488) Key Developments

Tianjin Tianyao Pharmaceuticals Co., Ltd., Board Meeting, Jun 17, 2014

Tianjin Tianyao Pharmaceuticals Co., Ltd., Board Meeting, Jun 17, 2014. Agenda: To discuss and approve issues including the proposal of agreeing Zhang Hui's resignation from positions of Director and Executive Deputy General Manager; to approve the proposal of nominating Zhang Jie Candidate for Director; and to approve the proposal of using some idle raised funds to temporarily supplement current capital.

Tianjin Tianyao Pharmaceuticals Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 03, 2014

Tianjin Tianyao Pharmaceuticals Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 03, 2014., at 14:30 China Standard Time. Agenda: To discuss the proposal of nominating Zhang Jie Candidate for Director and the proposal of adjusting application for fulfillment term for comprehensive credit lines.

Tianjin Tianyao Pharmaceutical Co., Ltd. Announces Board Changes

Tianjin Tianyao Pharmaceuticals Co., Ltd. held the 25th session of the 5th directorate meeting on April 28, 2014. At the meeting the board approved Yong Zhou's resignation from the position of Independent Director and nominating Zhou Xiaosu Candidate for Independent Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600488:CH CNY4.56 CNY 0.00

600488 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600488.
View Industry Companies
 

Industry Analysis

600488

Industry Average

Valuation 600488 Industry Range
Price/Earnings 100.0x
Price/Sales 3.1x
Price/Book 1.9x
Price/Cash Flow 98.0x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TIANYAO PHARM-A, please visit www.kingyork.biz/tianyaoyaoyeen. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.